BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, March 27, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 20, 2011
View Archived Issues
Preclinical and clinical data on migalastat made available
Read More
ViroPharma and Halozyme begin phase II trial of Cinryze with rHuPH20
Read More
Study identifies SNPs implicated in response to lithium therapy for bipolar disorder
Read More
BET subfamily inhibitor targets Myc-dependent malignancies
Read More
Inhibitor of P. aeruginosa type III secretion system shows promise in preclinical studies
Read More
Advanced Cancer Therapeutics and University of Louisville claim new cancer therapeutics
Read More
Fluorocoxib probe may allow earlier diagnosis of nonmelanoma skin cancer
Read More
Sanofi transfers Hyalgan rights back to Fidia Farmaceutici
Read More
Trius Therapeutics begins phase III tedizolid trials
Read More
Taisho sodium/glucose cotransporter 2 inhibitor shows promise in patients with type 2 diabetes
Read More
New fusion polypeptides disclosed
Read More
Aestus Therapeutics to develop in-licensed Prosidion product for new indication
Read More
Inhibitex begins dosing in phase II INX-189 study
Read More
Vaxin receives BARDA grant for anthrax vaccine
Read More
Bayer Schering Pharma prepares novel vasopressin receptor ligands
Read More
New angiotensin AT2 receptor antagonists/PPAR-gamma agonists synthesized by Kowa
Read More
Researchers at Almirall patent novel tyrosine-protein kinase inhibitors
Read More
Keryx Biopharmaceuticals completes enrollment in long-term Zerenex trial
Read More
OncoGenex expands inclusion criteria for SATURN study
Read More
Max-Planck-Gesellschaft and Sanofi partnership aims at restoring vision
Read More
FDA approves Prolia for new indications
Read More
Scripps Research Institute presents new fluorinated vinca alkaloids
Read More
Phase II Trimesta study reaches enrollment target
Read More
Sanofi Pasteur begins shipping Fluzone in U.S.
Read More
Takeda launches Liovel tablets in Japan
Read More
